FDA Approves New Device for CABG (Coronary Artery Bypass Graft Surgery
November 22, 2006 11:07

Cardica Inc. said it received clearance from the U.S. Food and Drug Administration to market its medical device C-Port xA in the United States. The C-Port xA, which is the next generation of the company's C-Port system, automates the attachments of blood vessels and grafts, such as those in coronary artery bypass graft surgeries.
The C-Port xA system is currently marketed in Europe.(Reuters)

Makers of Trasylol Failed to Tell the Truth to the FDA
November 22, 2006 11:08

Makers of Trasylol Failed to Tell the Truth to the FDAOur drug safety system relies heavily on pharmaceutical companies that market the drugs for information about their benefits and risks. These big pharma companies conduct the pre-market research and independent... (Read Article)